Back
FibroGen Quote, Financials, Valuation and Earnings
Sponsored
FGEN
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
61
FGEN
FibroGen
Last Price:
0.33
Seasonality Move:
40.41%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.FibroGen Price Quote
$0.33
-0.05 (-13.97%)
(Updated: November 13, 2024 at 5:55 PM ET)
FibroGen Key Stats
Buy
61
FibroGen (FGEN)
is a Buy
Day range:
$0.33 - $0.40
52-week range:
$0.29 - $2.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.22
P/B ratio:
0%
Volume:
3.3M
Avg. volume:
1.3M
1-year change:
0.92%
Market cap:
$38.5M
Revenue:
$147.8M
EPS:
$-1.71
How Much Does FibroGen Make?
Is FibroGen Growing As A Company?
FibroGen Stock Price Performance
What Is FibroGen 52-Week High & Low?
FibroGen Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy FibroGen?
Is FibroGen Cash Flow Positive?
FibroGen Return On Invested Capital
Data Unavailable
FibroGen Earnings Date & Stock Price
-
What Is FibroGen's Stock Price Today?
A single share of FGEN can be purchased today for 0.38 -
What Is FibroGen’s Stock Symbol?
FibroGen trades on the nasdaq under the ticker symbol: FGEN -
When Is FibroGen’s Next Earnings Date?
The next quarterly earnings date for FibroGen is scheduled on February 26, 2025 -
When Is FGEN's next ex-dividend date?
FibroGen's next ex-dividend date is November 14, 2024 -
How To Buy FibroGen Stock?
You can buy FibroGen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
FibroGen Competitors
FibroGen Dividend Yield
-
What Is FGEN Dividend Yield?
FibroGen’s dividend yield currently is 0% -
What Is FibroGen’s Payout Ratio?
FibroGen’s payout ratio is 0% -
When Did FibroGen Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is FibroGen’s Dividend Per Share?
FibroGen pays a dividend of $0.00 per share
FibroGen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 33.33% |
Revenue: | 14.27% | 46.1% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 0.60 |
Upside from Last Price: | 56.41% |